Efficacy and safety of cobimetinib (cobi) and atezolizumab (atezo) in an expanded phase 1b study of microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)
暂无分享,去创建一个
J. Desai | Y. Bang | E. Kwak | J. Bendell | J. Infante | M. Thakur | L. Chow | V. Heong | C. Chee | E. Cha | A. McRee | J. Wallin | Joo-Ran Kim | P. Foster | S. Han | Y. Hong | T. Kim | G. Mwawasi